Transcranial Direct Current Stimulation (tDCS)

• Effective, Drug-Free Treatment for Depression and Chronic Pain

Sooma tDCS™: Effective, Drug-Free Treatment for Depression and Chronic Pain

Sooma tDCS™ is an effective, safe, and clinically proven brain-stimulation therapy for depression, certified under the European Medical Device Regulation (MDR) for both clinical use and home-based care.

What Is Sooma tDCS™?

The brain communicates via electrical signals. In depression, neural signaling within the dorsolateral prefrontal cortex (DLPFC) is disrupted. Sooma tDCS™ targets this region using transcranial direct current stimulation (tDCS) to gently restore functional balance in affected brain areas—effectively and with minimal side effects. The therapy delivers a weak, low-intensity electrical current to the DLPFC via a portable stimulator and two electrodes positioned precisely using a specialized head cap. This non-invasive method can be applied either as a standalone intervention or in combination with other therapies, including conveniently at home. A typical treatment session lasts 20 to 30 minutes.

Why Choose Sooma tDCS™?

  •   Safe and painless – free from severe side effects and suitable for adults as well as older individuals.
  •   Proven, study-backed efficacy – the majority of patients experience and report at least a 50% reduction in symptoms.
  •   Scientifically validated – tDCS is recommended in international clinical guidelines as an effective treatment option.
  •   Trusted by clinics and specialized practices – over 150 clinical institutions and more than 25,000 patients rely on Sooma tDCS™.

Side Effects

Sooma tDCS™ does not cause serious adverse effects or undesirable interactions with other treatment modalities, such as pharmacotherapy or additional neuromodulation interventions. More than 33,000 stimulation sessions documented across clinical trials confirm the safety profile of this method. Occasional, mild side effects may include:

  •   Temporary tingling, itching, or mild redness at the electrode placement site
  •   Transient headaches or mild fatigue

Contraindications: Sooma tDCS™ is unsuitable for patients with metallic implants in the head region or acute skin irritations at the stimulation site.

Treatment Procedure

Sooma tDCS™ is always prescribed and supervised by a qualified healthcare professional. Each session typically lasts 20 to 30 minutes and can be self-administered independently at home following an initial guided instruction. We provide the patient with the Sooma tDCS™ device along with clear, easy-to-follow instructions. The companion Sooma smartphone app supports treatment adherence with session reminders and symptom-tracking questionnaires. Through the Sooma clinical portal, healthcare professionals program and monitor the therapy while managing patient profiles and individualized treatment protocols.